Correlation Between C4 Therapeutics and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Roivant Sciences, you can compare the effects of market volatilities on C4 Therapeutics and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Roivant Sciences.
Diversification Opportunities for C4 Therapeutics and Roivant Sciences
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CCCC and Roivant is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Roivant Sciences go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Roivant Sciences
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 3.24 times more return on investment than Roivant Sciences. However, C4 Therapeutics is 3.24 times more volatile than Roivant Sciences. It trades about 0.02 of its potential returns per unit of risk. Roivant Sciences is currently generating about 0.04 per unit of risk. If you would invest 361.00 in C4 Therapeutics on December 11, 2024 and sell it today you would lose (162.50) from holding C4 Therapeutics or give up 45.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. Roivant Sciences
Performance |
| Timeline |
| C4 Therapeutics |
| Roivant Sciences |
C4 Therapeutics and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Roivant Sciences
The main advantage of trading using opposite C4 Therapeutics and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| C4 Therapeutics vs. Shattuck Labs | ||
| C4 Therapeutics vs. Prelude Therapeutics | ||
| C4 Therapeutics vs. Monte Rosa Therapeutics | ||
| C4 Therapeutics vs. Foghorn Therapeutics |
| Roivant Sciences vs. Krystal Biotech | ||
| Roivant Sciences vs. Akero Therapeutics | ||
| Roivant Sciences vs. Apellis Pharmaceuticals | ||
| Roivant Sciences vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |